ALLO Archived Articles
Allogene Therapeutics (NASDAQ:ALLO): A Pioneer in Allogeneic CAR T-Cell Therapies Reshaping the Future of Cancer and Autoimmune Treatments
Published on November 04, 2024
Allogene Therapeutics, Inc. (ALLO): A Clinical-Stage Biotech Pioneering Allogeneic CAR T Therapies
Published on September 24, 2024